OTLC - Oncotelic Vectara team up to use AI tool to develop new cancer drugs

2023-04-19 13:34:05 ET

• Oncotelic Therapeutics ( OTCQB:OTLC ) is collaborating with Vectara , to accelerate the development of new therapies to treat cancer, infectious disease, and aging using Large Language Model (LLM) technology.
• A LLM is an artificial intelligence (AI) system that uses deep learning algorithms to generate natural language from a corpus of text, according to the company.
• Oncotelic's use cases show the potential for Vectara's LLM-powered search in areas of life sciences and healthcare, the companies added.
• "We are excited to combine Vectara's advanced NLU technology with our internal AI discovery and development programs to revolutionize drug discovery and development," said Oncotelic's Chief Business Officer Saran Saund.

For further details see: